|
|
|
Volumn 15, Issue 2, 2008, Pages 3967-3974
|
|
The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIRC5 PROTEIN, HUMAN;
CATHEPSIN B;
CYSTATIN;
CYSTATIN B;
CYSTEINE PROTEINASE INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MICROTUBULE ASSOCIATED PROTEIN;
SOMATOMEDIN BINDING PROTEIN;
TUMOR MARKER;
TUMOR PROTEIN;
BLOOD;
DISEASE COURSE;
GENETICS;
HUMAN;
MALE;
METABOLISM;
MORTALITY;
PATHOLOGY;
PREDICTION AND FORECASTING;
PROGNOSIS;
PROSTATE TUMOR;
REVIEW;
CATHEPSIN B;
CYSTATINS;
CYSTEINE PROTEINASE INHIBITORS;
DISEASE PROGRESSION;
HUMANS;
INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS;
MALE;
MICROTUBULE-ASSOCIATED PROTEINS;
NEOPLASM PROTEINS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
PROSTATIC NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 50349094623
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (18)
|
|
References (83)
|
